Within3 Secures Over $100M For Life Sciences Collaboration Tool
Summary
Pharmaceutical companies seeking feedback from heart surgeons, or academics publishing an article who need medical insights can often have difficulties engaging with the right people. Its intent is to foster meaningful discussions aimed at bringing drugs to market faster, publishing clinical studies, and gaining expert insights. “We looked for places within life sciences where communication was difficult, time-consuming and redundant, and we created virtual collaboration tools so they could work on different problems,” Lance Hill, CEO of Within3, told Crunchbase News. “Within3 is the premiere software available to researchers, manufacturers, regulators and health care professionals with nuanced solutions enabling large numbers of stakeholders to collaborate and communicate asynchronously, in a completely compliant and protected platform. The funding will be used to accelerate product innovation, build infrastructure to outpace growing demand, and expand internationally.
Funding
Classifications
AskAI Classifications
LabelsLinked Companies
